Feb 05, 2026 / 08:30PM GMT
Presentation at WORLDSymposiumâ¢
Feb 05, 2026 / 08:30PM GMT
=====================
Corporate Participants
=====================
* Ryan Watts
Denali Therapeutics Inc - President, Chief Executive Officer, Director
* Peter Chin
Denali Therapeutics Inc - Acting Chief Medical Officer, Head - Development
* Joe Lewcock
Denali Therapeutics Inc - Chief Scientific Officer
=====================
Conference Call Participants
=====================
* Andrew Tsai
Jefferies LLC - Analyst
* Salveen Richter
Goldman Sachs Group Inc - Analyst
* Mayank Mamtani
B. Riley Securities Holdings Inc - Analyst
* Tazeen Ahmad
Bofa Merrill Lynch Asset Holdings Inc - Analyst
* Michael Yee
UBS AG - Analyst
* Myles Minter
William Blair Capital Partners - Analyst
* Ananda Ghosh
H C Wainwright & Co LLC (Pre-Merger) - Equity Analyst
* Joseph Thome
Cowen and Company LLC - Analyst
* Marc Goodman
Leerink Partners LLC - Analyst
Denali Therapeutics Inc
(NAS:DNLI)
$
24.94
-0.75 (-2.92%)
Market Cap: 3.99 Bil
Enterprise Value: 3.31 Bil
PE Ratio: 0
PB Ratio: 4.77
GF Score: 33/100 Denali Therapeutics Inc Presentation at WORLDSymposium™ Transcript
Feb 05, 2026 / 08:30PM GMT
Release Date Price:
$20.02
(-5.92%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot